β2 ADRENERGIC RECEPTOR AGONISTS: NOVEL REGULATORS OF MACROPHAGE ACTIVATION IN DIABETIC RENAL AND CARDIOVASCULAR COMPLICATIONS

被引：0
|
作者：
Noh, Hyunjin [1 ]
Yu, Mi Ra [2 ]
Kim, Hyun Joo [2 ]
Lee, Si Nae [1 ]
King, George [3 ]
机构：
[1] Soon Chun Hyang Univ, Internal Med, Seoul, South Korea
[2] Soon Chun Hyang Univ, Hyonam Kidney Lab, Seoul, South Korea
[3] Joslin Diabet Ctr, Vasc Cell Biol, Boston, MA 02215 USA
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2016年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
SP376
引用
收藏
页码：214 / 214
页数：1
相关论文
共 50 条
  • [1] Beta 2-adrenergic receptor agonists are novel regulators of macrophage activation in diabetic renal and cardiovascular complications
    Noh, Hyunjin
    Yu, Mi Ra
    Kim, Hyun Joo
    Lee, Ji Hye
    Park, Byoung-Won
    Wu, I-Hsien
    Matsumoto, Motonobu
    King, George L.
    KIDNEY INTERNATIONAL, 2017, 92 (01) : 101 - 113
  • [2] Beta2 Adrenergic Receptor Agonists: Novel Regulator of Macrophage Activation in Diabetes
    Noh, Hyunjin
    Yu, Mi Ra
    Kim, Hyun Joo
    Park, Byoung-Won
    Chen, Kai
    Wu, I-Hsien
    Matsumoto, Motonobu
    King, George L.
    DIABETES, 2015, 64 : A138 - A138
  • [3] β2 Adrenergic Receptor Agonists as a Novel Treatment for CKD
    Arif, Ehtesham
    Medunjanin, Danira
    Solanki, Ashish K.
    Zuo, Xiaofeng
    Su, Yanhui
    Winkler, Brennan
    Palygin, Oleg
    Cornier, Marc-Andre
    Wolf, Bethany
    Hunt, Kelly J.
    Lipschutz, Joshua H.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 109 - 109
  • [4] β-Adrenergic receptor agonists attenuate pericyte loss in diabetic retinas through Akt activation
    Yun, Jang-Hyuk
    Jeong, Han-Seok
    Kim, Kyung-Jin
    Han, Man Hyup
    Lee, Eun Hui
    Lee, Kihwang
    Cho, Chung-Hyun
    FASEB JOURNAL, 2018, 32 (05): : 2324 - 2338
  • [5] Role of β2-Adrenergic Receptor Agonists in the Treatment of Diabetic Nephropathy
    Arif, Ehtesham
    Solanki, Ashish K.
    Wolf, Bethany
    Hunt, Kelly J.
    Lipschutz, Joshua H.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 265 - 265
  • [6] β2-Adrenergic receptor agonists as a treatment for diabetic kidney disease
    Arif, Ehtesham
    Medunjanin, Danira
    Solanki, Ashish
    Zuo, Xiaofeng
    Su, Yanhui
    Dang, Yujing
    Winkler, Brennan
    Lerner, Kasey
    Kamal, Ahmed I.
    Palygin, Oleg
    Cornier, Marc-Andre
    Wolf, Bethany J.
    Hunt, Kelly J.
    Lipschutz, Joshua H.
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2024, 326 (01) : F20 - F29
  • [7] PP2A activation by β2-adrenergic receptor agonists -: Novel regulatory mechanism of keratinocyte migration
    Pullar, CE
    Chen, J
    Isseroff, RR
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (25) : 22555 - 22562
  • [8] β2-Adrenergic receptor agonists: a new treatment for diabetic kidney disease?
    Liu, Zhiwen
    Dong, Zheng
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2024, 326 (01) : F1 - F2
  • [9] Novel β3 adrenergic receptor agonists.
    Yanai, M
    Takahashi, T
    Kawamura, K
    Ueno, M
    Hiramoto, S
    Katsuyama, K
    Fuchizawa, S
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 220 : U590 - U590
  • [10] Cardiovascular and renal effects of novel nonpeptide nociceptin opioid peptide receptor agonists
    Denys, Ian B.
    Gao, Juan
    Sutphen, Jane C.
    Zaveri, Nurulain T.
    Kapusta, Daniel R.
    BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (02) : 287 - 300
12345